JP2016513472A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513472A5
JP2016513472A5 JP2016502468A JP2016502468A JP2016513472A5 JP 2016513472 A5 JP2016513472 A5 JP 2016513472A5 JP 2016502468 A JP2016502468 A JP 2016502468A JP 2016502468 A JP2016502468 A JP 2016502468A JP 2016513472 A5 JP2016513472 A5 JP 2016513472A5
Authority
JP
Japan
Prior art keywords
culture medium
cell population
cells
pge2
contacted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016502468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513472A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/027521 external-priority patent/WO2014152603A1/en
Publication of JP2016513472A publication Critical patent/JP2016513472A/ja
Publication of JP2016513472A5 publication Critical patent/JP2016513472A5/ja
Pending legal-status Critical Current

Links

JP2016502468A 2013-03-15 2014-03-14 幹細胞培養培地及び細胞生存を増強する方法 Pending JP2016513472A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361792818P 2013-03-15 2013-03-15
US61/792,818 2013-03-15
PCT/US2014/027521 WO2014152603A1 (en) 2013-03-15 2014-03-14 Stem cell culture media and methods of enhancing cell survival

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020000736A Division JP2020089373A (ja) 2013-03-15 2020-01-07 幹細胞培養培地及び細胞生存を増強する方法

Publications (2)

Publication Number Publication Date
JP2016513472A JP2016513472A (ja) 2016-05-16
JP2016513472A5 true JP2016513472A5 (OSRAM) 2017-04-20

Family

ID=51581254

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016502468A Pending JP2016513472A (ja) 2013-03-15 2014-03-14 幹細胞培養培地及び細胞生存を増強する方法
JP2020000736A Pending JP2020089373A (ja) 2013-03-15 2020-01-07 幹細胞培養培地及び細胞生存を増強する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020000736A Pending JP2020089373A (ja) 2013-03-15 2020-01-07 幹細胞培養培地及び細胞生存を増強する方法

Country Status (7)

Country Link
US (2) US9943545B2 (OSRAM)
EP (1) EP2970894A4 (OSRAM)
JP (2) JP2016513472A (OSRAM)
CN (1) CN105358679A (OSRAM)
AU (1) AU2014239290B2 (OSRAM)
CA (1) CA2906641C (OSRAM)
WO (1) WO2014152603A1 (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012315699B2 (en) * 2011-09-30 2017-08-17 Bluebird Bio, Inc. Compounds for improved viral transduction
CN107406830A (zh) 2014-12-30 2017-11-28 细胞治疗神经科学有限公司 Rpe细胞群和制备它们的方法
CN114058582A (zh) 2015-01-26 2022-02-18 菲特治疗公司 用于诱导造血细胞分化的方法和组合物
US10233210B2 (en) * 2015-01-30 2019-03-19 Coral Drugs Pvt. Ltd. Process for preparation of glucocorticoid steroids
KR20180033537A (ko) 2015-07-21 2018-04-03 더 칠드런스 메디칼 센터 코포레이션 Pd-l1 발현 조혈 줄기 세포 및 용도
CN115927199A (zh) 2015-11-04 2023-04-07 菲特治疗公司 用于诱导造血细胞分化的方法和组合物
ES2953925T3 (es) 2015-11-04 2023-11-17 Fate Therapeutics Inc Ingeniería genómica de células pluripotentes
CN105713880A (zh) * 2016-04-20 2016-06-29 广东艾时代生物科技有限责任公司 一种造血干细胞体外扩增培养的无血清培养基及其应用
CN105749252B (zh) * 2016-04-29 2025-11-14 南方医科大学 Il-9作为治疗血小板缺少症的药物的应用
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
CN106434549A (zh) * 2016-12-20 2017-02-22 江西宜信堂医疗科技有限公司 一种无血清干细胞培养基及其制备方法
KR102018609B1 (ko) * 2017-04-26 2019-09-06 이장호 중간엽 줄기세포 배양액을 포함하는 세포 또는 조직의 동결보존용 조성물
US11879137B2 (en) 2017-09-22 2024-01-23 The Children's Medical Center Corporation Treatment of type 1 diabetes and autoimmune diseases or disorders
AU2018393494A1 (en) * 2017-12-29 2020-07-09 Cell Cure Neurosciences Ltd. Retinal pigment epithelium cell compositions
JP7036670B2 (ja) * 2018-05-31 2022-03-15 アークレイ株式会社 血液中の稀少細胞検査、該検査ための血液処理方法及び採血管
CN110894490A (zh) * 2018-09-13 2020-03-20 李陶 一种脐带造血干细胞体外扩增培养体系和脐带造血干细胞体外扩增方法
EP3870189A4 (en) * 2018-10-24 2022-09-28 Hebecell Corporation Methods and systems for manufacturing hematopoietic lineage cells
WO2020190888A1 (en) * 2019-03-18 2020-09-24 Advanced ReGen Medical Technologies, LLC Methods and clinical protocols and kits pertaining to making and using therapeutic compositions for cellular treatment
CN110317782B (zh) * 2019-07-18 2023-06-13 天津瑞博斯生物技术有限公司 提高间充质干细胞复苏后存活的方法和所用的冻存液
CN112779209B (zh) * 2019-11-08 2023-01-24 合肥中科普瑞昇生物医药科技有限公司 原代乳腺上皮细胞培养基、培养方法及其应用
CN110923194B (zh) * 2019-12-23 2021-08-13 广东依浦赛生物科技有限公司 一种原代细胞培养的方法
TWI888659B (zh) * 2021-10-13 2025-07-01 芯芮生技開發股份有限公司 幹細胞條件培養基於製備抑制癌症組成物的用途
CN116889226A (zh) * 2022-04-02 2023-10-17 杭州启函生物科技有限公司 Nk细胞冻存液
KR20250020610A (ko) * 2022-06-03 2025-02-11 블루록 테라퓨틱스 엘피 세포 전달 비히클 및 이를 사용하는 방법

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5635387A (en) 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5460964A (en) 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US5405772A (en) 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
US5677136A (en) 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
EP0891419A4 (en) 1996-03-12 2000-03-01 Life Technologies Inc NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
DE69834630T2 (de) 1997-02-20 2007-04-19 Dsm Ip Assets B.V. Fermentative herstellung von wertstoffen in industriellem umfang durch verwendung von chemisch definierten media
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
AU2183900A (en) 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
JP2000201672A (ja) * 1999-01-11 2000-07-25 Asahi Medical Co Ltd 有核細胞の凍結保存用組成物
US6822112B1 (en) 1999-08-13 2004-11-23 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
DE60120007T2 (de) 2000-01-31 2006-11-16 Pfizer Products Inc., Groton Verwendung von Aktivatoren des Prostaglandinrezeptores 4 zur Behandlung von akuter oder chronischer Niereninsuffizienz
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7968329B2 (en) * 2000-10-06 2011-06-28 Michael Dancu Method of conditioning a hybrid synthetic tubular structure to yield a functional human hybrid coronary bypass graft
JP2003225084A (ja) 2000-12-28 2003-08-12 Japan Science & Technology Corp 凍結細胞保存剤
FR2825261B1 (fr) 2001-06-01 2003-09-12 Maco Pharma Sa Ligne de prelevement du sang placentaire comprenant une poche de rincage
IL162648A0 (en) 2001-12-21 2005-11-20 Mount Sinai Hospital Corp Cellular compositions and methods of making and using them
US7176022B2 (en) * 2002-12-20 2007-02-13 Cell Genesys, Inc. Directly injectable formulations which provide enhanced cryoprotection of cell products
US6747037B1 (en) 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
WO2006047476A2 (en) 2004-10-26 2006-05-04 Allergan, Inc. Therapeutic and delivery methods of prostaglandin ep4 agonists
JP2008531051A (ja) 2005-02-28 2008-08-14 リジェネテック,インコーポレイテッド すぐに利用できる末梢血由来の細胞物質を提供する方法およびその組成
KR20080027295A (ko) * 2005-06-02 2008-03-26 스템사이트, 인코포레이티드 혈장-제거되고, 적혈구-비제거된 제대혈 조성물 및 사용방법
DE102005062741A1 (de) 2005-12-22 2007-06-28 Bayer Schering Pharma Ag Fluorene und Carbazole als Liganden des EP2 Rezeptors
RU2493252C2 (ru) * 2006-03-24 2013-09-20 Чилдрен'З Медикал Сентер Корпорейшн Способ стимулирования экспансии гематопоэтических стволовых клеток
WO2008034803A1 (en) * 2006-09-18 2008-03-27 Medizinische Universität Graz Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
RU2480213C2 (ru) 2006-10-20 2013-04-27 Чилдрен'З Медикал Сентер Корпорейшн Способ стимуляции регенерации тканей
WO2008073748A1 (en) 2006-12-08 2008-06-19 University Of Rochester Expansion of hematopoietic stem cells
CN105766891A (zh) * 2008-08-20 2016-07-20 人类起源公司 改进的细胞组合物及制备所述组合物的方法
WO2010054271A1 (en) * 2008-11-06 2010-05-14 Indiana University Research & Technology Corporation Materials and methds to enhance hematopoietic stem cells engraftment procedures
EP3533445A1 (en) 2009-03-19 2019-09-04 Fate Therapeutics, Inc. Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same
NZ623454A (en) 2009-05-20 2015-12-24 Cardio3 Biosciences Sa Pharmaceutical composition for the treatment of heart diseases
US11459545B2 (en) 2009-11-15 2022-10-04 Indiana University Research And Technology Corporation Methods to enhance delivery and engraftment of stem cells including the identification of specific prostaglandin E2 receptors
JP5773347B2 (ja) * 2009-11-27 2015-09-02 国立大学法人 千葉大学 血液細胞の凍結保存剤
US20140030232A1 (en) 2010-08-12 2014-01-30 Fate Therapeutics, Inc. Hematopoietic stem and progenitor cell therapy
TWI535377B (zh) * 2011-09-01 2016-06-01 Storage, culture and application of umbilical cord tissue and its derived cells
WO2013055476A1 (en) * 2011-09-09 2013-04-18 Anthrogenesis Corporation Treatment of amyotrophic lateral sclerosis using placental stem cells
AU2012321088B8 (en) 2011-12-02 2016-12-15 Fate Therapeutics, Inc. Enhanced stem cell composition
ES2682255T3 (es) 2011-12-02 2018-09-19 Fate Therapeutics, Inc. Métodos mejorados de tratamiento de isquemia
EP2968416A4 (en) 2013-03-15 2016-08-17 Fate Therapeutics Inc CELL POTENTIAL TEST FOR THERAPEUTIC POTENTIAL

Similar Documents

Publication Publication Date Title
JP2016513472A5 (OSRAM)
JP2020089373A5 (OSRAM)
US11162076B2 (en) Methods and compositions for inducing hematopoietic cell differentiation
Jung et al. Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells
Bao et al. Chemically-defined albumin-free differentiation of human pluripotent stem cells to endothelial progenitor cells
Zuk Adipose‐derived stem cells in tissue regeneration: a review
JP2022033900A (ja) グルコース依存性ミトコンドリア呼吸及び二相インスリン分泌応答を示すヒト多能性幹細胞由来の機能的ベータ細胞の生成
KR101138091B1 (ko) 중간엽 줄기세포 기본 배양 배지 조성방법, 중간엽 줄기세포 기본 배양 배지 및 이를 이용하여 배양분화된 세포치료제
JP6636427B2 (ja) 小分子を用いるヒト多能性幹細胞からの内分泌始原細胞の作製
JP6949336B2 (ja) 人工多能性幹細胞由来腸管幹細胞の維持培養
Sart et al. Process engineering of stem cell metabolism for large scale expansion and differentiation in bioreactors
Lee et al. Enhancement of osteogenic and chondrogenic differentiation of human embryonic stem cells by mesodermal lineage induction with BMP-4 and FGF2 treatment
Koellensperger et al. Choosing the right type of serum for different applications of human adipose tissue–derived stem cells: influence on proliferation and differentiation abilities
CN105358679A (zh) 干细胞培养基和增加细胞存活的方法
TW200927927A (en) Stem cell medium
CN108060126B (zh) 一种诱导分化的细胞制备间充质干细胞的方法及调控靶点的组合
JPWO2019182044A1 (ja) 多分化能性幹細胞分化促進剤
Mohammadi-Sangcheshmeh et al. Isolation, characterization, and mesodermic differentiation of stem cells from adipose tissue of camel (Camelus dromedarius)
Kim et al. Characterization of human fetal cartilage progenitor cells during long-term expansion in a xeno-free medium
CN105814193A (zh) 胰岛样细胞结构及其制备方法
CN111607556B (zh) 一种培养扩增人肝祖细胞的培养基及其应用
US20230002729A1 (en) Cell culture medium composition
Van Hoof et al. Directed differentiation of human pluripotent stem cells along the pancreatic endocrine lineage
US20240352419A1 (en) Methods and compositions for differentiation of pluripotent stem cells and derived hematopoietic lineage cells
US20240316196A1 (en) Methods and compositions for differentiation of pluripotent stem cells and derived natural killer cells